Position in BEAM
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$595
-$5,775 QoQ
Shares Held
25
-90.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascentis Independent Advisors holds $30,103 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100 | $30,103 |
All Filings in BEAM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $595 | 25 | Shares | Sole | 2026-04-28 | |
| 2024-09-30 | $6,370 | 260 | Shares | Sole | 2024-10-29 | |
| 2022-03-31 | $555,237 | 9,690 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $525,954 | 6,600 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||